Zollinger-Ellison phenotype in the absence of hypergastrinemia and islet-cell tumor.
Patients with the Zollinger-Ellison syndrome are characterized by islet-cell tumors, striking gastric acid hypersecretion, and peptic ulcer disease. They often experience severe abdominal pain, diarrhea, and gastrointestinal bleeding with potentially life-threatening consequences. It is a rare syndrome caused by non-beta cell islet-cell tumors (gastrinomas) located in or in proximity to the pancreas. These tumors freely secrete gastrin, a peptide hormone that serves as a powerful stimulant of gastric acid secretion. Exuberant secretion of gastrin from the gastrinomas produces severe gastric acid hypersecretion that often leads to impressive peptic ulcer disease and the constellation of symptoms listed above. We describe a patient presenting with clinical manifestations characteristic of the ZES with strikingly elevated gastric acid secretion,multiple ulcers in the first and second portions of the duodenum and diarrhea, but in absence of islet-cell tumor and/or hypergastrinemia.
Desai
Anish A
AA
University of Florida, Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, Gainesville, FL 32610, USA. desaiaa@medicine.ufl.edu
McGuigan
James E
JE
Draganov
Peter
P
D007516:Adenoma, Islet Cell; D003967:Diarrhea / Q000209:etiology*; D004381:Duodenal Ulcer / Q000473:pathology*; D005744:Gastric Acid / Q000378:metabolism*; D005755:Gastrins / Q000097:blood; D006801:Humans; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms; D010641:Phenotype; D015043:Zollinger-Ellison Syndrome / Q000473:pathology*
D005755:Gastrins